Ledger.Open graph →
SEC Form D · filed November 23, 2021

Sermonix Pharmaceuticals, Inc

Offering
$40.2M
Sold
$40.2M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
COLUMBUS, OH
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (22)

Miriam Portman · Columbus, OHExec · PromoterDavid Portman · Columbus, OHExec · Director · PromoterThomas Pfisterer · Columbus, OHDirectorElizabeth Attias · Columbus, OHExecMichael Friedman · Chicago, ILDirectorSimon Jenkins · Columbus, OHExecElizabeth Garner · Columbus, OHDirectorAnthony Wild · Columbus, OHExec · DirectorRichard De Schutter · Columbus, OHDirectorBarry Komm · Columbus, OHExecPaul Plourde · Columbus, OHExecElizabeth Attias · Columbus, OHExecMichael Friedman · Cranston, RIDirectorSimon Jenkins · Columbus, OHExecElizabeth Garner · Columbus, OHDirectorMiriam Portman · Columbus, OHExec · PromoterAnthony Wild · Columbus, OHExec · DirectorDavid Portman · Columbus, OHExec · Director · PromoterRichard De Schutter · Columbus, OHDirectorBarry Komm · Columbus, OHExecThomas Pfisterer · Columbus, OHDirectorPaul Plourde · Columbus, OHExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗